Does CLINDAMYCIN\CLOTRIMAZOLE Cause Bladder transitional cell carcinoma? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Bladder transitional cell carcinoma have been filed in association with CLINDAMYCIN\CLOTRIMAZOLE. This represents 90.9% of all adverse event reports for CLINDAMYCIN\CLOTRIMAZOLE.
10
Reports of Bladder transitional cell carcinoma with CLINDAMYCIN\CLOTRIMAZOLE
90.9%
of all CLINDAMYCIN\CLOTRIMAZOLE reports
0
Deaths
10
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From CLINDAMYCIN\CLOTRIMAZOLE?
Of the 10 reports, 10 (100.0%) required hospitalization.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLINDAMYCIN\CLOTRIMAZOLE. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does CLINDAMYCIN\CLOTRIMAZOLE Cause?
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)